Primary Job Title Co-founder and Managing Director Primary Organization TIO Bioventures
Location New York, New York, United States Regions Greater New York Area, East Coast, Northeastern US Gender Male
Tak Wah Mak is the Co-founder and Managing Director of TIO Bioventures and the co-founder of TIO Bioventures’ flagship portfolio company Treadwell Therapeutics. Best known for discovering and first cloning the T cell receptor and identifying the function of the CTLA-4 immune checkpoint protein, Dr. Tak Wah Mak is recognized as one of the world’s
leading scientists.
Tak Wah Mak holds an MSc from the University of Wisconsin and a PhD from the University of Alberta.
